AstraZeneca
LON:AZN ISIN:GB0009895292
AstraZeneca is a major international healthcare business engaged in research, development, manufacturing and marketing of prescription pharmaceuticals and supplier for healthcare services. AstraZeneca is one of the world's leading pharmaceutical companies with healthcare sales of US$29.55 billion and is a leader in gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infection product sales. AstraZeneca is listed in the Dow Jones Sustainability Index (Global) as well as the FTSE4Good Index.
查看其它语言版本
新闻
Adairs从首募至上市始终获得投资人强烈关注，澳交所首秀股价涨超10%，报于2.65元，盘中最高触及2.68元，3200万份股票换手，相当于总股本的五分之一。该家居及床上用品零售商IPO发行价2.4澳元，共计筹得2.181亿澳元，由瑞银和高盛保荐承销，IPO阶段认购需求强烈以致缩减新股配发规模。Adairs在全澳运营131家分店，同时进行网络销售，今年拟将增加8-12家店面且有海外扩张计划；本财年预计盈利2070万澳元，销售额提升17.5%，达2.033亿澳元。发行价相当于16.3倍市盈率。
###
7,836 公司背景浏览
- 本页浏览人次: (过去7日: 7) (过去30日: 28) (自发布以来: 3674)
